Skip to main content
. 2021 Jan 22;23(4):376–385. doi: 10.4103/aja.aja_84_20

Table 4.

Descriptive statistics (mean±standard deviation) for the 2PN, 1PN, 3PN, lysed, fertilization failure (0PN), cleavage formation, blastocyst formation, and clinical pregnancy rates in the asthenozoospermic subgroup

Groups A-NP (n=56) A-IM (n=57) A-M (n=182) OAT (n=356) N (n=162)
2PN rate 0.7358±0.0559N,A-M,OAT 0.7260±0.0519N,A-M,OAT 0.7620±0.0484N,A-NP,A-IM,OAT 0.5977±0.0752* 0.8242±0.0499*
1PN rate 0.0107±0.0307 0.0078±0.0237 0.0147±0.0292 0.018±0.039 0.0056±0.0199
3PN rate 0.0260±0.0448 0.0153±0.0392 0.0201±0.038 0.0514±0.0543 0.0078±0.0211
Lysed rate 0.0176±0.0411 0.0193±0.0411 0.0153±0.0321 0.0355±0.0497 0.0076±0.0218
0PN rate 0.2099±0.0644N,OAT 0.2317±0.0704N,A-M,OAT 0.1880±0.0687N,A-IM,OAT 0.2460±0.0749* 0.1551±0.0511*
Cleavage formation rate 0.8190±0.0835A-IM,OAT 0.7138±0.0906 0.8045±0.0729A-IM,OAT 0.78±0.10 0.801±0.087A-IM,OAT
Blastocyst formation rate 0.4871±0.0585 0.4390±0.0642N 0.4672±0.0496 0.4526±0.0681N 0.4835±0.0411A-IM,OAT
Clinical pregnancy rate, n/total (%) 18/56 (32.14) 21/57 (36.84) 73/182 (40.11) 115/356 (32.30) 73/162 (45.06)

A Kruskal–Wallis test and a Wilcoxon post hoc analysis were employed for the statistical evaluation. Statistical significance is set at P=0.00625. The letters in superscript indicate statistically significant differences for their respective groups. *Statistically significant differences for all other groups. PN: pronuclei; A-NP: nonprogressive asthenozoospermic group; A-IM: the immotility group; A-M: the mild asthenozoospermic subgroup; OAT: oligoasthenoteratozoospermia; N: normal semen analysis